Simbec-Orion MBO Underpins Build And Buy Strategy

Private equity group CBPE Capital acquires majority stake in UK CRO and will finance expansion into US; deal provides Welsh Life Sciences Investment Fund with first exit.

Closed up finger on keyboard with word CLINICAL TRIALS

With backing from private equity group CBPE Capital, Simbec-Orion is on the hunt for assets to increase its US presence. The private equity group, through its £459m CBPE Capital Fund IX, has financed a management buyout at the CRO and is committed to providing further finance for further international growth and expansion by Simbec-Orion. CBPE acquired its majority stake by buying the stake owned by the Welsh Government-backed Welsh Life Sciences Investment Fund.

Created in 2014 by the merger of Simbec Research and Orion Group, Simbec-Orion has been on a fast growth trajectory...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D